Corrigendum: Investigating Pregnancy and Its Complications Using Circulating Cell-Free RNA in Women's Blood During Gestation (Front.Pediatr (2020), 8, (605219), 10.3389/fped.2020.605219)

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

In the original article, the Conflict of Interest statement was inadvertently incomplete. The statement should include: “SQ is a founder and shareholder of Mirvie, and Stanford University and the Chan Zuckerberg Biohub have filed patents based on the work of SQ and MM on the use of cfRNA in maternal and fetal health.

Cite

CITATION STYLE

APA

Moufarrej, M. N., Wong, R. J., Shaw, G. M., Stevenson, D. K., & Quake, S. R. (2021, April 12). Corrigendum: Investigating Pregnancy and Its Complications Using Circulating Cell-Free RNA in Women’s Blood During Gestation (Front.Pediatr (2020), 8, (605219), 10.3389/fped.2020.605219). Frontiers in Pediatrics. Frontiers Media S.A. https://doi.org/10.3389/fped.2021.680201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free